Overview

Aurinia Renal Response in Active Lupus With Voclosporin

Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of voclosporin compared with placebo in achieving renal response after 52 weeks of therapy in subjects with active lupus nephritis.
Phase:
Phase 3
Details
Lead Sponsor:
Aurinia Pharmaceuticals Inc.
Treatments:
Calcineurin Inhibitors
Cyclosporine